Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance.

George A KarpouzasZoltán SzekaneczEva BaecklundTed R MikulsDeepak L BhattCunshan WangGosford A SawyerrYan ChenSujatha MenonCarol A ConnellSteven R YtterbergMahta Mortezavi

Published in: Therapeutic advances in musculoskeletal disease (2023)

NCT02092467.

Keyphrases

rheumatoid arthritis
disease activity
rheumatoid arthritis patients
ankylosing spondylitis
public health
juvenile idiopathic arthritis
interstitial lung disease
systemic lupus erythematosus
idiopathic pulmonary fibrosis